Chargement de la fiche…
rhumatologie
Dr Azeddine Dellal
Hospitalier
Montfermeil (93370)
Vasculitis and related conditions · Systemic Lupus Erythematosus Research · Otitis Media and Relapsing Polychondritis
0Publications
0Citations
0Citations de la publi la +
Publications actives
Côté patient
Avant votre rendez-vous avec le Dr Azeddine Dellal
Choisissez votre pathologie pour une explication en langage simple.
Parcourir toutes les pathologies →Des applications évaluées par MonRhumato, sélectionnées pour les patients.
MapathoPlateforme communautaire maladies chroniques + annuaire pair-validé
GustaveAgent IA souverain pour information patient sourcée
Remedee LabsBracelet stimulateur d'endorphines pour douleur chroniquePourquoi consulter Dr Azeddine Dellal
- Auteur de référence en rhumatologie
- Référence presse grand public
- Délais de RDV courts dans la région
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
Parcours
2018–2026
Groupe Hospitalier Intercommunal Le Raincy Montfermeil
2024
University of Indonesia
2020–2024
Hôpital Cochin
2022–2024
Assistance Publique – Hôpitaux de Paris
2024
University College London
2024
Comenius University Bratislava
Rayonnement scientifique
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 12 articles cités au moins 12fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Dernières publications
Publications les plus citées
89 citationsInterleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial2021 · Annals of the rheumatic diseasesPubMed ↗39 citationsIschemic stroke in giant-cell arteritis: French retrospective study2019 · Journal of autoimmunityPubMed ↗38 citationsArthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study2019 · Autoimmunity reviewsPubMed ↗
Diplômes & qualifications
DES
Rhumatologie (SM) — Diplôme d'Études Spécialisées
CES
Aide médicale urgente · DIU Etudes approfondies polyarthrites-maladies · Diplôme équivalent d'un pays hors EEE profession Médecin — Capacité / Certificat d'Études Spéciales
DU / DIU
DIU Études approfondies polyarthrites & maladies auto-immunes
Le DIU rhumato généraliste de référence : polyarthrite rhumatoïde, spondyloarthrite, lupus, Sjögren, vascularites. Coordonné par la SFR.
Plusieurs universités, coordination Société Française de Rhumatologie (SFR)
Lieu d'exercice
Domaines d'expertise
Vasculitis and related conditionsSystemic Lupus Erythematosus ResearchOtitis Media and Relapsing PolychondritisRenal Diseases and GlomerulopathiesBiosimilars and Bioanalytical Methods
Bibliométrie (OpenAlex)
Profil ↗0
travaux
0
h-index
0
i10-index
0
citations
Vasculitis and related conditionsSystemic Lupus Erythematosus ResearchOtitis Media and Relapsing PolychondritisRenal Diseases and GlomerulopathiesBiosimilars and Bioanalytical Methods
Transversal
112026Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Prognosis and Long-Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis
2024RMD open
PubMed ↗Higher risk profile among patients with TET2-mutated giant cell arteritis: a cluster analysis
2024Bone
PubMed ↗Trabecular bone score (TBS) in Cushing's disease: TBS gain after hypercortisolism normalization
2023Clinical and experimental medicine
PubMed ↗Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases
2022Clinical rheumatology
PubMed ↗UBA1 gene mutation in giant cell arteritis
2022Orphanet journal of rare diseases
PubMed ↗Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum
2021European journal of haematology
PubMed ↗White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective study
2021Viruses
PubMed ↗D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients
2020Frontiers in medicine
PubMed ↗Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study
2020Seminars in arthritis and rheumatism
PubMed ↗Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study
2019Journal of autoimmunity
PubMed ↗Ischemic stroke in giant-cell arteritis: French retrospective study
Vascularites des gros vaisseaux
52026RMD open
PubMed ↗Salvage therapy with JAK inhibitors in refractory Takayasu arteritis: a multicentre experience
2025Rheumatology (Oxford, England)
PubMed ↗Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study
2024NEJM evidence
PubMed ↗Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome
2023RMD open
PubMed ↗Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
2021Scientific reports
PubMed ↗Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu Arteritis
Anti-TNF
42026Rheumatology and therapy
PubMed ↗Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study
2025Rheumatology (Oxford, England)
PubMed ↗Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study
2024NEJM evidence
PubMed ↗Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome
2024BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
PubMed ↗Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study
Biothérapies non-anti-TNF
32023RMD open
PubMed ↗Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
2022Ocular immunology and inflammation
PubMed ↗Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves' Orbitopathy
2020Rheumatology (Oxford, England)
PubMed ↗Efficacy and safety of rituximab for autoimmune neutropenia: a French case series and literature review
Épidémiologie & registres
32026Joint bone spine
PubMed ↗AA amyloidosis in inflammatory joint diseases in the era of biological therapies: Prevalence, manifestations, management and evolution
2024Rheumatology (Oxford, England)
PubMed ↗Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry
2022RMD open
PubMed ↗Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
Revue générale
32021Rheumatology (Oxford, England)
PubMed ↗TNF inhibitors for the management of inflammatory heart disease in spondyloarthritis: French multicentre case-series and literature review
2020Autoimmunity reviews
PubMed ↗Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review
2019Rheumatology (Oxford, England)
PubMed ↗Thrombotic microangiopathy associated with anti-neutrophil cytoplasmic antibody-associated vasculitis: a French nationwide retrospective case-control study and literature review
Sjögren
32021Annals of the rheumatic diseases
PubMed ↗Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
2020Clinical and experimental rheumatology
PubMed ↗Primary Sjögren's syndrome: central and peripheral nervous system involvements
2019Autoimmunity reviews
PubMed ↗Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study
csDMARDs
2Risque cardio-vasculaire
2Publications HAL
82026Article
Cardiovascular risk among Giant cells arteritis patients.
European Journal of Preventive Cardiology
2026Article
Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study
Rheumatology and Therapy
2025Article
Comment on: Hydroxychloroquine levels in pregnancy and materno–fetal outcomes in Systemic Lupus Erythematosus patients: Reply
Rheumatology
2024Article
Higher risk profile among patients with TET2-mutated giant cell arteritis: a cluster analysis
RMD Open
2024Article
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study
BioDrugs
2023Article
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
RMD Open
2023Article
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study
The Lancet Rheumatology
2022Article
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases
Clinical and Experimental Medicine
Rhumatologues à proximité
Données issues de l'Annuaire Santé (ANS) — Licence Ouverte 2.0. Enrichissements à partir de sources publiques. Vous êtes le praticien référencé ? Faites corriger ou retirer votre fiche : demande de rectification ou de retrait.